Canakinumab for Severe COVID-19, Medical Debt in the US, Novel Lipid-Lowering Therapies, and more

JAMA Editor’s Summary

Canakinumab for Severe COVID-19, Medical Debt in the US, Novel Lipid-Lowering Therapies, and more

Editors' Summary by Kristin Walter, MD, Associate Editor of JAMA, the Journal of the American Medical Association, for the issue.

July 20, 2021

Listen on your favorite player Take me to this show’s page

Newer →

Heart Failure Quality Improvement RCT, 7 vs 14 Days of Antibiotics for Male UTI, Does This Patient Have Hypertension?, and more

← Older

Platelet-Rich Plasma for Achilles Tendinopathy, Delivery for Suspected Fetal Growth Restriction, Review of Alcohol-Related Liver Disease, and more

Facebook Twitter Buffer LinkedIn WhatsApp

Canakinumab for Severe COVID-19, Medical Debt in the US, Novel Lipid-Lowering Therapies, and more

Editors’ Summary by Kristin Walter, MD, Associate Editor of JAMA, the Journal of the American Medical Association, for the July 20, 2021 issue.

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Join Our Newsletter

We gratefully acknowledge the many organizations that have generously supported our podcasts and platform.

Network Sponsors and Advertisers

Event and Media Partners

00:00

00:00